Your browser is no longer supported. Please, upgrade your browser.
OCX OncoCyte Corporation monthly Stock Chart
OCX [AMEX]
OncoCyte Corporation
Index- P/E- EPS (ttm)-0.48 Insider Own0.10% Shs Outstand65.83M Perf Week4.65%
Market Cap98.20M Forward P/E- EPS next Y-0.33 Insider Trans- Shs Float56.92M Perf Month-19.64%
Income-26.30M PEG- EPS next Q-0.09 Inst Own40.50% Short Float3.07% Perf Quarter-46.64%
Sales0.16M P/S621.51 EPS this Y-5.00% Inst Trans-1.11% Short Ratio2.13 Perf Half Y-48.28%
Book/sh0.60 P/B2.25 EPS next Y25.00% ROA-61.40% Target Price- Perf Year-17.68%
Cash/sh0.24 P/C5.74 EPS next 5Y- ROE-88.00% 52W Range1.20 - 3.51 Perf YTD-40.00%
Dividend- P/FCF- EPS past 5Y-17.40% ROI- 52W High-61.54% Beta2.62
Dividend %- Quick Ratio2.70 Sales past 5Y- Gross Margin- 52W Low12.50% ATR0.19
Employees33 Current Ratio2.70 Sales Q/Q- Oper. Margin- RSI (14)38.26 Volatility11.35% 9.69%
OptionableYes Debt/Eq0.11 EPS Q/Q-33.60% Profit Margin- Rel Volume0.87 Prev Close1.46
ShortableYes LT Debt/Eq0.07 EarningsJul 29 AMC Payout- Avg Volume817.87K Price1.35
Recom2.40 SMA20-0.18% SMA50-37.17% SMA200-38.76% Volume715,587 Change-7.53%
Jul-30-20Reiterated The Benchmark Company Speculative Buy $7 → $6
Jul-01-20Downgrade Piper Sandler Overweight → Neutral
Jun-30-20Downgrade Chardan Capital Markets Buy → Neutral $2
Jun-02-20Initiated Needham Buy $4
Feb-13-19Initiated Piper Jaffray Overweight $6
Jan-29-19Upgrade Janney Neutral → Buy
Dec-19-18Resumed Lake Street Buy
Jul-29-20 06:45PM  
04:05PM  
Jul-20-20 04:05PM  
08:00AM  
Jul-16-20 08:00AM  
Jul-14-20 08:00AM  
Jul-02-20 10:54AM  
Jun-30-20 07:41AM  
Jun-29-20 04:05PM  
Jun-17-20 10:32AM  
Jun-15-20 08:00AM  
Jun-10-20 04:18PM  
May-13-20 05:51PM  
May-12-20 04:05PM  
May-05-20 08:00AM  
08:00AM  
May-01-20 08:00AM  
Apr-30-20 02:21PM  
Apr-24-20 08:00AM  
Apr-23-20 08:00AM  
Apr-15-20 10:55PM  
Apr-07-20 03:35PM  
09:00AM  
08:00AM  
Mar-25-20 04:05PM  
02:30PM  
Mar-19-20 08:00AM  
Mar-18-20 08:00AM  
Feb-05-20 08:00AM  
Jan-30-20 08:00AM  
Jan-13-20 08:00AM  
Jan-10-20 04:05PM  
Jan-07-20 08:00AM  
Jan-02-20 08:08PM  
Dec-23-19 02:19PM  
Dec-09-19 11:42AM  
Nov-27-19 08:00AM  
Nov-14-19 04:05PM  
Nov-11-19 12:15PM  
Nov-08-19 08:00AM  
Oct-31-19 08:00AM  
Oct-15-19 08:00AM  
Oct-09-19 08:12AM  
Oct-01-19 08:00AM  
Sep-19-19 10:09AM  
Sep-05-19 08:00AM  
Aug-14-19 04:05PM  
Jul-31-19 08:00AM  
Jul-26-19 05:08PM  
Jul-24-19 08:00AM  
Jul-11-19 03:30PM  
11:28AM  
Jul-09-19 05:08PM  
Jul-07-19 05:33PM  
Jul-02-19 04:22PM  
02:23PM  
Jun-26-19 09:05AM  
Jun-25-19 08:37AM  
Jun-11-19 04:35PM  
08:00AM  
Jun-06-19 06:30AM  
May-29-19 04:05PM  
07:00AM  
May-21-19 03:15PM  
May-20-19 10:20AM  
May-14-19 11:44PM  
04:18PM  
04:05PM  
02:30PM  
May-08-19 04:01PM  
Apr-25-19 08:00AM  
Apr-24-19 12:06PM  
Apr-01-19 04:20PM  
04:06PM  
04:05PM  
02:30PM  
Mar-25-19 04:05PM  
Mar-20-19 11:05AM  
Mar-06-19 04:15PM  
Mar-04-19 04:05PM  
Feb-14-19 08:00AM  
Feb-12-19 04:05PM  
Feb-08-19 09:00AM  
Feb-07-19 04:05PM  
Jan-31-19 11:05AM  
Jan-30-19 12:15PM  
08:30AM  
08:00AM  
Jan-29-19 02:30PM  
02:14PM  
10:25AM  
08:47AM  
07:14AM  
Jan-28-19 04:30PM  
Jan-03-19 08:00AM  
Dec-20-18 04:18PM  
Nov-30-18 10:38AM  
Nov-26-18 07:50AM  
Nov-19-18 04:05PM  
Nov-13-18 06:08PM  
OncoCyte Corporation engages in the development and commercialization of non-invasive blood-based diagnostic tests for the early detection of cancer. The company is developing DetermaVu, a non-invasive molecular lung cancer confirmatory diagnostic that is administered to patients as a blood test. It also develops diagnostic tests based on liquid biopsies for detecting breast cancer. The company was founded in 2009 and is headquartered in Irvine, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BROADWOOD PARTNERS, L.P.10% OwnerApr 24Buy2.271,050,0002,383,50014,716,204Apr 28 06:14 PM
ANDREWS RONALD ASBURYCEO and PresidentMar 31Buy2372.0018,00042,696,00062,698Apr 01 04:05 PM
ANDREWS RONALD ASBURYCEO and PresidentMar 30Buy2.2627,21661,45444,698Apr 01 04:05 PM
Levine Mitchell SChief Financial OfficerMar 14Option Exercise0.0020,000033,495Apr 20 04:42 PM
BROADWOOD PARTNERS, L.P.10% OwnerJan 02Buy2.161,391,4663,000,00113,666,204Jan 06 06:38 PM
BROADWOOD PARTNERS, L.P.10% OwnerNov 13Buy1.701,176,4712,000,00112,274,738Nov 15 05:57 PM